新型大孔隙磷酸钙骨水泥作为骨组织工程支架的相关研究

目的 探讨新型大孔隙磷酸钙骨水泥(CPC)材料支架的细胞毒性和对细胞黏附、生长和增殖的影响.方法 通过添加甘露醇制孔剂和应用磷酸钠溶液作为CPC固化液的方法合成新型CPC材料.通过CCK8法检测细胞在新型CPC材料浸提液中的生长增殖情况;通过电子扫描电镜测试材料孔径和细胞在材料表面上黏附生长情况;应用力学三点弯曲实验测试新型CPC的生物力学性能.结果 新型CPC材料的孔径值达到(267.43±118.01)μm,孔隙率为(66.15±6.91)％.新型CPC材料的最大负荷、抗弯强度和坚韧度较传统CPC均增加了约1倍(P＜0.05).新型CPC材料浸提液与细胞共培养2、4、6、8d后CCK8法测试吸光度(OD)值与阴性对照组比较其差异无统计学意义(P＞0.05).结论 新型CPC材料具有强大的生物力学性能、大孔隙、高孔隙率和良好的生物相容性,有望成为理想的骨组织工程支架.     

纳米晶重组类人胶原基/聚乳酸复合支架材料的表征及细胞相容性研究

目的　制备纳米羟基磷灰石/重组类人胶原基/聚乳酸复合支架材料 (nano-hydroxyapatite/ recombinant human- like collagen/polylactic acid,nHA/RHLC/PLA),观察材料的形貌特征,探讨材料对骨髓基质干细胞(BMSCs)增殖、黏附及分化等生物学行为的影响。 方法　制备nHA/RHLC/PLA复合支架材料,应用X 光衍射分析（XRD）、红外光谱分析（FTIR）、ZWICK Z005 测试机对样品的化学成分、机械性能测试和压缩强度进行测试,通过扫描电镜检查等方法观察材料的表征;将犬骨髓基质细胞（BMSCs）接种在支架材料上培养,检测材料-细胞的黏附情况及材料对细胞生长增殖的影响。 结果　nHA/RHLC/PLA复合支架材料压缩强度均大于1MPa,达到了天然松质骨的最低强度。扫描电镜结果显示：支架材料呈三维多孔结构,孔为不规则多边形,孔的走向多样,纵向和横向孔隙互为交通,孔径在几十微米到300微米不等,孔隙率为75%~83%。nHA/RHLC/PLA复合支架材料表面BMSCs的黏附、生长良好;而BMSCs的增殖能力与对照组相比,差异无显著性意义(P>0.05)。 结论　nHA/RHLC/PLA复合支架材料符合组织工程骨支架的力学要求,具有良好的微观结构,无细胞毒性,细胞与支架生物相容性良好。利用重组类人胶原代替动物源性胶原制备纳米晶骨修复材料,规避了动物胶原交叉感染的风险,有望成为一种理想的骨组织工程支架材料。     

基于3D打印的Ⅰ型胶原涂覆β-TCP骨组织工程支架研究

根据骨缺损形态构建个性化的组织工程支架在骨组织工程应用中有巨大需求。基于3D打印技术制备个性化的I型胶原涂覆的β-磷酸三钙(β-TCP)骨支架。通过比较0/90°、0/60°、0/45°的填充角度,0.10、0.25、0.50 mg/m L涂覆胶原的浓度对β-TCP支架孔径、孔隙率、力学性能的影响,选定最优填充角度为0/90°及最佳涂覆胶原的浓度为0.50 mg/m L的β-TCP/胶原支架。所得支架能准确地再现设计的三维模型,具有多级孔结构,大孔平均直径为315μm,微孔直径为3~5μm,孔隙率为84%。β-TCP/胶原支架的抗压能力为(12.29±0.88)MPa,压缩弹性模量为(116.74±27.75)MPa,与成人松质骨相似。体外大鼠骨髓间充质干细胞(m BMSCs)支架培养实验结果显示,涂覆胶原的支架具有更好的生物相容性,能有效促进m BMSCs的粘附增殖,β-TCP/胶原支架上细胞具有更高的碱性磷酸酶(ALP)活性和Collagen-I、BSP相关成骨基因的表达。研究结果显示,3D打印制备的I型胶原涂覆的β-TCP支架具有匹配的外形,良好可控的孔隙率,对m BMSCs有良好成骨活性,为骨组织支架在临床上应用提供新的技术。     

壳聚糖-脱细胞真皮三维材料作为骨组织工程支架材料的研究

目的观察MC3T3-El成骨前体细胞在壳聚糖-脱细胞真皮三维支架材料上的黏附情况,并评价其细胞相容性。方法通过冷冻干燥制备壳聚糖-脱细胞真皮三维支架材料,并测试其孔隙率、密度和吸水率,通过扫描电镜分析支架的微观形貌。采用体外培养细胞的方法,将MC3T3-E1细胞直接接种到壳聚糖-脱细胞真皮三维支架材料上,培养2,3,4,5h,各时间点各取3个样品,测定细胞在支架上的黏附率,确定最佳的细胞贴壁时间。将细胞接种到支架上,共培养1,3,5,7,9,11,13d,采用MTS方法绘制细胞增殖曲线,组织化学染色观察细胞形态,并利用材料试验机测试不同时间材料细胞复合物的压缩弹性模量。结果壳聚糖-脱细胞真皮材料具有连通的多孔结构,孔隙率为92.8%,密度为97.96g/L,吸水率为(2169±100)%。细胞相容性实验显示,成骨细胞易于在支架材料上黏附、增殖。结论壳聚糖-脱细胞真皮材料具有连通的孔隙,孔径较均匀,MC3T3-El成骨前体细胞易在壳聚糖-脱细胞真皮三维支架材料上黏附、增殖,表明该支架材料具有良好的细胞相容性。     

I型胶原-壳聚糖复合材料的生物相容性研究*

目的评价I型胶原-壳聚糖复合材料作为组织工程支架材料的生物相容性。方法体外培养兔骨髓间充质干细胞﹙BMSCs﹚,采用四甲基偶氮唑盐﹙MTT﹚比色法检测不同分组的BMSCs生长情况,酶标仪测吸光度值﹙OD﹚,计算细胞相对增值率﹙RGR%﹚;利用材料浸提液与兔新鲜血混合观察红细胞溶解情况,评价材料细胞生物相容性。结果空白组﹙A组﹚,50%浓度组﹙B组﹚和100%浓度组﹙C组﹚BMSCs均生长良好,并于1、3、5天逐渐增殖,阳性对照组﹙D组﹚细胞于第1天开始变圆、皱缩,3天和5天均皱缩死亡。A、B、C三组细胞在第1、3、5天各组吸光度值无显著差异﹙P>0.05﹚,但均与D组有明显统计学差异﹙P<0.05﹚。材料相对溶血率为4.1%。结论 I型胶原-壳聚糖复合材料无明显细胞毒性,有良好的生物相容性。     

冷冻干燥法制备聚乳酸多孔支架

冷冻干燥法制备聚乳酸(polylactic acid,PLA)多孔支架材料。将0.5 g PLA干燥24 h后加入到4 mL有机溶剂(1,4-二氧六环/二氯甲烷,v/v)中,按体积比分为3组(n=5)(A组,95:5;B组,90:10;C组:85:15)混合。冷冻干燥箱内冷冻干燥24 h,对其表面形貌、孔隙率、抗压强度以及细胞毒性进行检测。扫描电镜显示PLA支架内部孔隙分布均匀,孔隙率在(68.97±0.12)%～(73.75±0.48)%之间,差异有统计学意义(P0.05);抗压强度在(2.90±0.53)～(4.11±0.05) MPa之间,差异有统计学意义(P0.05);体外细胞毒性检测结果显示,材料浸提液不影响细胞的增值,表现出良好的细胞相容性。冷冻干燥法能制备出符合骨组织要求的PLA多孔支架材料。     

脱细胞随机肌腱支架促进骨髓间充质干细胞骨向分化

目的:探究随机肌腱细胞外基质(ECM)支架对骨髓间充质干细胞(BMSCs)活力和分化的影响。方法:从Sprague-Dawley大鼠股骨和胫骨中提取BMSCs,体外培养,观察细胞形态,并利用流式细胞术鉴定细胞干性。采用1%Triton X-100和DNase/RNase混合液对鼠尾肌腱进行脱细胞处理,利用HE染色和DNA含量测定考察肌腱组织中细胞核残余情况。制备胶原纤维随机排列的肌腱ECM支架,培养BMSCs,以孔板中生长的细胞为对照组,利用Live/Dead染色和CCK8法考察细胞的活力和形态;利用RT-qPCR检测肌腱标志物I型胶原蛋白(Col I)、肌腱特异转录因子scleraxis(SCX)及成骨标志物碱性磷酸酶(ALP)和Runt相关转录因子2(RUNX2)的表达水平。结果:HE染色结果显示,经过脱细胞处理后肌腱组织内无细胞残余,且DNA含量从(481.7±15.8)μg/g显著性降至(31.0±3.8)μg/g(P<0.05),脱细胞处理成功。7 d时,种植在支架上的BMSCs的活力较对照组显著增强(P<0.05);14 d时,种植在支架上的BMSCs肌腱标志物Col I和SCX的表达量较对照组显著下调,而成骨标志物ALP和RUNX2的表达量较对照组显著上调(P<0.05)。结论:脱细胞随机肌腱ECM支架能增强BMSCs活力,并诱导其向成骨细胞分化。     

三维打印双相磁性纳米复合支架材料的性能测定

目的研究制备出一种新型双相磁性纳米复合支架材料(PLGA/Col-I-PLGA/n-HA/Fe_2O_3),通过各项生物学性能检测,评价并探讨其作为骨组织工程支架的可行性。方法通过低温快速成型方法制备双相磁性纳米复合支架材料(PLGA/Col-I-PLGA/n-HA/Fe_2O_3),采用电子试验机检测支架材料的抗弯,抗压,弹性模量评价其力学性能,通过电镜观察支架材料超微结构;以介质(乙醇)浸泡法测定支架材料的孔隙率,将支架材料与骨髓间充质干细胞复合共培养,检测其生物相容性。结果双相磁性纳米复合支架材料力学检测结果显示其具有良好的力学性能,电镜观察结果显示上下两层孔径均匀分布,上层软骨相孔径较小,中间连续相良好融合,孔径及孔隙率检测结果显示软骨层支架的孔径为189um,孔隙率86.5%。骨层支架的孔径为364um,孔隙率77.1%,符合双层支架材料的设计要求。双相磁性纳米复合支架材料与骨髓间充质干细胞共培养,结果显示骨髓间充质干细胞的增殖效果很好,能更好的促进分化为目的细胞,说明双相磁性纳米复合支架材料具有良好的生物相容性。结论双相磁性纳米复合支架材料(PLGA/Col-I-PLGA/n-HA/Fe_2O_3)有很好的力学性能和生物相容性,孔径及孔隙率达到细胞粘附生长的要求,与正常的关节软骨及软骨下骨生理结构更加接近,有望可以更好的修复骨关节炎或者外伤等疾病带来的软骨和软骨下骨损伤。     

生物活性玻璃/壳聚糖/羟基磷灰石复合骨修复材料制备及细胞相容性研究

目的设计一种生物活性玻璃/壳聚糖/羟基磷灰石(BG/HA/CS)复合材料的骨组织工程支架,并对其理化性能和细胞相容性进行检测。方法不同比例的BG/HA/CS混合液用冷冻干燥法制备成支架。通过计算支架孔隙率;扫描电镜、X线衍射和傅立叶红外光谱分析其微观形貌和组成;采用材料试验机进行支架的机械性能检测,并评价生物活性玻璃的加入对支架的影响。将第3代兔骨髓间充质干细胞接种于支架上,使用扫描电镜检测支架对其粘附作用,采用MTT法检测细胞在支架上增殖,并评价生物活性玻璃的加入对支架的细胞相容性影响。结果合成的BG/CS/HA支架与模具拥有同样的大小及几何形状,具有相互贯通的多孔结构,未见生物活性玻璃聚集,孔隙率最高可达86.96%,孔径大小合适(100~300um),最大压缩强度为(1.95±0.13)Mpa。X射线衍射图可以看到特征性的BG衍射峰;傅立叶变换红外光谱可见特征的BG吸收峰,这表明材料内有明确的BG;第3代兔骨髓间充质干细胞在支架上共培养1天后,细胞在支架表面粘附。部分细胞伸展,并伸出伪足。共培养5天后,可见细胞数目增多,团聚,细胞表面可见微绒毛,细胞已开始向材料内部迁移。采用MTT法测量骨髓间充质干细胞在支架上的增殖情况可以看出骨髓间充质干细胞在BG/CS/HA支架上表现出了明显的增殖。结论采用溶液共混、冷冻干燥法可以制备出BG/CS/HA支架;支架具有良好的孔隙率,较好的机械强度,良好的组织相容性,可用于骨组织工程。     

3D打印聚己内酯/纳米羟基磷灰石复合支架与骨髓间充质干细胞的体外生物相容性

文题释义： 3D打印技术：是通过计算机设计3D模型,按照某一坐标轴切成无限多个剖面,然后层层打印堆叠形成一个实体的立体模型,使用3D打印技术制备的骨组织工程支架能对支架的内部结构和外形进行自由可控的构建,在支架个性化、精确性、机械强度、孔隙调节、空间结构复杂性方面有独特优势。 纳米羟基磷灰石/聚己内酯复合材料：羟基磷灰石是人体和动物骨骼的主要无机成分,具有良好的骨诱导性,纳米羟基磷灰石由于良好的生物相容性和骨整合能力被广泛用作骨缺损的修复材料;聚己内酯是一种已被FDA批准的生物材料,具有良好的机械性能、生物相容性及降解性。两种材料复合物的多孔结构能够为细胞生长、组织再生及血管化提供有利条件。 背景：聚己内酯/纳米羟基磷灰石复合材料是在常用骨组织工程材料基础上结合3D打印技术制备的新型复合支架材料,目前对于该复合材料的体外生物相容性研究较少。 目的：通过体外实验探讨3D打印聚己内酯/纳米羟基磷灰石复合支架材料的细胞相容性。 方法：利用3D打印技术分别制备聚己内酯及聚己内酯/纳米羟基磷灰石复合支架,表征两组材料的微观结构、孔隙率及力学性能。将大鼠骨髓间充质干细胞分别接种于两组支架表面,CCK-8法检测细胞增殖率,扫描电镜和Live/Dead染色观察细胞在支架上的生长情况。 结果与结论：①两组支架均呈三维网状相互连通结构,纤维呈规律有序的排列、相互交错,纤维表面无空隙,纤维间距、直径较为均一;两组支架的孔隙率比较差异无显著性意义(P > 0.05);复合支架的弹性模量高于单纯聚己内酯支架(P < 0.05);②两组支架表面培养1 d的细胞增殖比较差异无显著性意义(P > 0.05),复合支架表面培养4,7 d的细胞增殖快于单纯聚己内酯支架(P < 0.05);③Live/Dead染色结果显示,两组材料均具有良好的细胞相容性,细胞活性较高,同时复合支架上的贴壁细胞更多一些;④扫描电镜显示,细胞在两种材料上生长形态良好,并紧密黏附于支架表面及微孔附近,同时可见分泌的细胞外基质呈丝状包绕于细胞周围;⑤结果表明,3D打印技术制备的聚己内酯/纳米羟基磷灰石复合支架孔隙较丰富,具备良好的力学性能,细胞相容性良好,可作为骨组织工程的支架材料。 ORCID: 0000-0002-7083-6458(胡超然) 中国组织工程研究杂志出版内容重点：生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程     

The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4

The ability of a cellular construct to guide and promote tissue repair strongly relies on three components, namely, cell, scaffold and growth factors. We aimed to investigate the osteopromotive properties of cellular constructs composed of poly-epsilon-caprolactone (PCL) and rabbit bone marrow stromal cells (BMSCs), or BMSCs engineered to express bone morphogenetic protein 4 (BMP4). Highly porous biodegradable PCL scaffolds were obtained via phase inversion/salt leaching technique. BMSCs and transfected BMSCs were seeded within the scaffolds by using an alternate flow perfusion system and implanted into non-critical size defects in New Zealand rabbit femurs. In vivo biocompatibility, osteogenic and angiogenic effects induced by the presence of scaffolds were assessed by histology and histomorphometry of the femurs, retrieved 4 and 8 weeks after surgery. PCL without cells showed scarce bone formation at the scaffold-bone interface (29% bone/implant contact and 62% fibrous tissue/implant contact) and scarce PCL resorption (16%). Conversely, PCL seeded with autologous BMSCs stimulated new tissue formation into the macropores of the implant (20%) and neo-tissue vascularization. Finally, the BMP4-expressing BMSCs strongly favoured osteoinductivity of cellular constructs, as demonstrated by a more extensive bone/scaffold contact.     

Fabrication and characterization of chitosan/OGP coated porous poly(ε-caprolactone) scaffold for bone tissue engineering

As one of the stimulators on bone formation, osteogenic growth peptide (OGP) improves both proliferation and differentiation of the bone cells in vitro and in vivo. The aim of this work was the preparation of three dimensional porous poly(ε-caprolactone) (PCL) scaffold with high porosity, well interpore connectivity, and then its surface was modified by using chitosan (CS)/OGP coating for application in bone regeneration. In present study, the properties of porous PCL and CS/OGP coated PCL scaffold, including the microstructure, water absorption, porosity, hydrophilicity, mechanical properties, and biocompatibility in vitro were investigated. Results showed that the PCL and CS/OGP-PCL scaffold with an interconnected network structure have a porosity of more than 91.5, 80.8%, respectively. The CS/OGP-PCL scaffold exhibited better hydrophilicity and mechanical properties than that of uncoated PCL scaffold. Moreover, the results of cell culture test showed that CS/OGP coating could stimulate the proliferation and growth of osteoblast cells on CS/OGP-PCL scaffold. These finding suggested that the surface modification could be a effective method on enhancing cell adhesion to synthetic polymer-based scaffolds in tissue engineering application and the developed porous CS/OGP-PCL scaffold should be considered as alternative biomaterials for bone regeneration.     

Biocompatibility and osteogenicity of degradable Ca-deficient hydroxyapatite scaffolds from calcium phosphate cement for bone tissue engineering

Ca-deficient hydroxyapatite (CDHA) porous scaffolds were successfully fabricated from calcium phosphate cement (CPC) by a particle-leaching method. The morphology, porosity and mechanical strength as well as degradation of the scaffolds were characterized. The results showed that the CDHA scaffolds with a porosity of 81% showed open macropores with pore sizes of 400-500mum. Thirty-six per cent of these CDHA scaffolds were degraded after 12 weeks in Tris-HCl solution. Mesenchymal stem cells (MSCs) were cultured, expanded and seeded on the scaffolds, and the proliferation and differentiation of MSCs into osteoblastic phenotype were determined using MTT assay, alkaline phosphatase activity and scanning electron microscopy. The results revealed that the CDHA scaffolds were biocompatible and had no negative effects on the MSCs in vitro. The in vivo biocompatibility and osteogenicity of the scaffolds were investigated. Both CDHA scaffolds and MSC/scaffold constructs were implanted in rabbit mandibles and studied histologically. The results showed that CDHA scaffolds exhibited good biocompatibility and osteoconductivity. Moreover, the introduction of MSCs into the scaffolds dramatically enhanced the efficiency of new bone formation, especially at the initial stage after implantation (from 2 to 4 weeks). However, the CDHA scaffolds showed as good biocompatibility and osteogenicity as the hybrid ones at 8 weeks. These results indicate that the CDHA scaffolds fulfill the basic requirements of bone tissue engineering scaffold.     

多孔HA/PU复合支架材料生物相容性的评估

进行了三维多孔立体结构的纳米羟基磷灰石/聚氨酯(HA/PU)复合支架材料体外细胞培养和体内肌肉埋植实验研究,评估材料的生物相容性。实验选用SD大鼠的骨髓基质干细胞(BMSCs)和健康的SD雌性大鼠,进行细胞相容性、形态学观察和组织学切片分析。HA/PU支架材料的多孔性为细胞的生长提供了良好的微环境,细胞在内部贴壁爬行、增殖并分化,细胞毒性为零级,材料与周围组织有良好的结合,降解的空间有结缔组织纤维长入。实验表明,HA/PU复合支架材料具有良好的细胞亲和性和组织学相容性,可作为一类新型组织工程支架材料。     

Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro

Computer-aided tissue-engineering approach was used to develop a novel precision extrusion deposition (PED) process to directly fabricate Polycaprolactone (PCL) and composite PCL/hydroxyapatite (PCL-HA) tissue scaffolds. The process optimization was carried out to fabricate both PCL and PCL-HA (25% concentration by weight of HA) with a controlled pore size and internal pore structure of the 0 degrees /90 degrees pattern. Two groups of scaffolds having 60% and 70% porosity and with pore sizes of 450 and 750 microm, respectively, were evaluated for their morphology and compressive properties using scanning electron microscopy (SEM) and mechanical testing. Our results suggested that inclusion of HA significantly increased the compressive modulus from 59 to 84 MPa for 60% porous scaffolds and from 30 to 76 MPa for 70% porous scaffolds. In vitro cell-scaffolds interaction study was carried out using primary fetal bovine osteoblasts to assess the feasibility of scaffolds for bone tissue-engineering application. The cell proliferation and differentiation were calculated by Alamar Blue assay and by determining alkaline phosphatase activity. The osteoblasts were able to migrate and proliferate over the cultured time for both PCL as well as PCL-HA scaffolds. Our study demonstrated the viability of the PED process to the fabricate PCL and PCL-HA composite scaffolds having necessary mechanical property, structural integrity, controlled pore size and pore interconnectivity desired for bone tissue engineering.     

Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds

Tissue engineering approaches using the combination of porous ceramics and bone marrow mesenchymal stem cells (BMSCs) represent a promising bone substitute for repairing large bone defects. Nevertheless, optimal conditions for constructing tissue-engineered bone have yet to be determined. It remains unclear if transplantation of predifferentiated BMSCs is superior to undifferentiated BMSCs or freshly isolated bone marrow mononucleated cells (BMNCs) in terms of new bone formation in vivo. The aim of this study was to investigate the effect of in vitro osteogenic differentiation (β-glycerophosphate, dexamethasone, and l-ascorbic acid) of human BMSCs on the capability to form tissue-engineered bone in unloaded conditions after subcutaneous implantation in nude mice. After isolation from human bone marrow aspirates, BMNCs were divided into three parts: one part was seeded onto porous beta-tricalcium phosphate ceramics immediately and transplanted in a heterotopic nude mice model; two parts were expanded in vitro to passage 2 before cell seeding and in vivo transplantation, either under osteogenic conditions or not. Animals were sacrificed for micro-CT and histological evaluation at 4, 8, 12, 16, and 20 weeks postimplantation. The results showed that BMSCs differentiated into osteo-progenitor cells after induction, as evidenced by the altered cell morphology and elevated alkaline phosphatase activity and calcium deposition, but their clonogenicity, proliferating rate, and seeding efficacy were not significantly affected by osteogenic differentiation, compared with undifferentiated cells. Extensive new bone formed in the pores of all the scaffolds seeded with predifferentiated BMSCs at 4 weeks after implantation, and maintained for 20 weeks. On the contrary, scaffolds containing undifferentiated BMSCs revealed limited bone formation only in 1 out of 6 cases at 8 weeks, and maintained for 4 weeks. For scaffolds with BMNCs, woven bone was observed sporadically only in one case at 8 weeks. Overall, this study suggests that ectopic osteogenesis of cell/scaffold composites is more dependent on the in vitro expansion condition, and osteo-differentiated BMSCs hold the highest potential concerning in vivo bone regeneration.     

聚乳酸-羟基乙酸共聚物/硅酸钙三维多孔骨组织工程支架的构建与性能

BACKGROUND: Some disadvantages exsist in commonly used poly(lactic-co-glycolic acid) (PLGA) scaffolds, including acidic degradation products, suboptimal mechanical properties, low pore size, poor porosity and pore connectivity rate and uncontrollable shape. OBJECTIVE: To construct a scaffold with three-dimensional (3D) pores by adding calcium silicate to improve the properties of PLGA, and then detect its degradability, mechanical properties and biocompatibility. METHODS: PLGA/calcium silicate porous composite microspheres were prepared by the emulsion-solvent evaporation method, and PLGA 3D porous scaffold was established by 3D-Bioplotter, and then PLGA/calcium silicate composite porous scaffolds were constructed by combining the microspheres with the scaffold using low temperature fusion technology. The compositions, morphology and degradability of the PLGA/calcium silicate porous composite microspheres and PLGA microspheres, as well as the morphology, pore properties and compression strength of the PLGA 3D scaffolds and PLGA/calcium silicate composite porous scaffolds were measured, respectively. Mouse bone marrow mesenchymal stem cells were respectively cultivated in the extracts of PLGA/calcium silicate porous composite microspheres and PLGA microspheres, and then were respectively seeded onto the PLGA 3D scaffolds and PLGA/calcium silicate composite porous scaffolds. Thereafter, the cell proliferation activity was detected at 1, 3 and 5 days. RESULTS AND CONCLUSION: Regular pores on the PLGA microspheres and internal cavities were formed, and the PH values of the degradation products were improved after adding calcium silicate. The fiber diameter, pore, porosity and average pore size of the composite porous scaffolds were all smaller than those of the PLGA scaffolds. The compression strength and elasticity modulus of the composite porous scaffolds were both higher than those of the PLGA scaffolds (P < 0.05). Bone marrow mesenchymal stem cells grew well in above microsphere extracts and scaffolds. These results indicate that PLGA/calcium silicate composite porous scaffolds exhibit good degradability in vitro, mechanical properties and biocompatibility.     

Solid Free-Form Fabrication-Based PCL/HA Scaffolds Fabricated with a Multi-head Deposition System for Bone Tissue Engineering

In this study, we fabricated polycaprolactone/hydroxyapatite (PCL/HA) scaffolds with a multi-head deposition system, a solid free-form fabrication technology that was developed in our previous study. The bone regeneration potential of the scaffolds was compared with that of PCL scaffolds fabricated with the same system. The fabricated scaffolds had a pore size of 400 μm and a porosity of 66.7%. The PCL/HA scaffolds had higher mechanical strength and modulus than the PCL scaffolds. To compare the osteogenic potential, the two types of scaffolds were seeded with rat osteoblasts and cultured in vitro or implanted subcutaneously into athymic mice. The cells cultured on PCL/HA scaffolds expressed higher levels of osteopontin and osteonectin, both of which are osteogenic proteins. The PCL/HA scaffolds resulted in larger bone area and calcium deposition in the implants compared to the PCL scaffolds.     

基于三维打印的磷酸三钙骨组织工程支架烧结工艺研究

磷酸三钙(TCP)是构建骨组织工程支架常用的生物陶瓷材料。三维(3D)打印的TCP支架具有精确可控的孔隙结构,但存在力学性能不足的问题。由于烧结工艺对生物陶瓷支架力学性能的影响至关重要,本文详细探讨了不同烧结温度对3D打印TCP支架的力学性能的影响,测试了不同烧结温度制备的支架的表观形貌、质量和体积收缩率、孔隙率、力学性能以及降解性能。结果表明,当烧结温度为1150℃时,晶粒生长充分、气孔最少,支架具有最大的体积收缩率、最小的孔隙率以及最优的力学性能,压缩模量和抗压强度可以分别达到(100.08±18.6)MPa和(6.52±0.84)MPa,能够满足人体松质骨力学强度的要求。此外,与其他烧结温度下制备的支架相比,1150℃下烧结制备的支架在酸性环境中降解最慢,进一步说明其在长期植入时具有更佳的力学稳定性。该支架可支持骨髓间充质干细胞(BMSCs)黏附和快速增殖,具有良好的生物相容性。综上,本文优化了3D打印TCP支架的烧结工艺,提高了其力学性能,为其作为承重骨的应用奠定了基础。     

Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts

Three-dimensional (3D) culture systems are critical to investigate cell physiology and to engineer tissue grafts. In this study, we describe a simple yet innovative bioreactor-based approach to seed, expand, and differentiate bone marrow stromal cells (BMSCs) directly in a 3D environment, bypassing the conventional process of monolayer (two-dimensional [2D]) expansion. The system, based on the perfusion of bone marrow-nucleated cells through porous 3D scaffolds, supported the formation of stromal-like tissues, where BMSCs could be cocultured with hematopoietic progenitor cells in proportions dependent on the specific medium supplements. The resulting engineered constructs, when implanted ectopically in nude mice, generated bone tissue more reproducibly, uniformly, and extensively than scaffolds loaded with 2D-expanded BMSCs. The developed system may thus be used as a 3D in vitro model of bone marrow to study interactions between BMSCs and hematopoietic cells as well as to streamline manufacture of osteoinductive grafts in the context of regenerative medicine.